Journal of the neurological sciences
-
Nocebo is very prevalent among neurological disorders, resulting in low adherence and treatment outcome. We sought to examine the adverse events (AE) following placebo administration in placebo-controlled randomized clinical trials (RCTs) for chronic inflammatory demyelinating polyneuropathy (CIDP). ⋯ Compared to other neurological diseases the nocebo effect in CIDP is significantly smaller.